https://pharmadog.xyz/news/162282 pharmadog en 2026-07-30T07:00:00.000Z Biopharma layoffs in 2026 often marred by impersonal and poorly timed communications https://pharmadog.xyz/news/162281 pharmadog en 2026-07-30T07:00:00.000Z Four biotech firms secure Series B funding and open new hiring opportunities https://pharmadog.xyz/news/161941 pharmadog en 2026-07-30T04:32:19.000Z Johnson & Johnson prepares $2.58 billion option to acquire Sail Biomedicines, expanding in-vivo CAR-T portfolio https://pharmadog.xyz/news/161798 pharmadog en 2026-07-30T04:17:00.000Z Biogen’s early Phase 2 data supports tau-targeting Alzheimer’s approach https://pharmadog.xyz/news/161709 pharmadog en 2026-07-30T04:05:00.000Z Red Bull-funded studies downplay risks of mixing energy drinks with alcohol, shaping policy despite independent warnings https://pharmadog.xyz/news/160693 pharmadog en 2026-07-29T22:43:56.000Z FDA advisory panel votes 9-3 against Capricor's Duchenne therapy deramiocel https://pharmadog.xyz/news/160280 pharmadog en 2026-07-29T21:36:13.000Z NSF launches $47 million pilot to create joint university-industry Ph.D. programs for life scientists https://pharmadog.xyz/news/160477 pharmadog en 2026-07-29T21:31:00.000Z FDA advisory panel rejects Capricor's Duchenne heart-cell therapy deramiocel https://pharmadog.xyz/news/160201 pharmadog en 2026-07-29T21:22:00.000Z MapLight Therapeutics' mid-stage schizophrenia trial shows modest improvement but shares plunge two-thirds https://pharmadog.xyz/news/160181 pharmadog en 2026-07-29T21:00:00.000Z Latigo's mid-stage trial shows non-opioid pill LTG-001 cuts post-surgery pain, outperforms placebo https://pharmadog.xyz/news/159841 pharmadog en 2026-07-29T19:48:29.000Z FTC sues Hims & Hers over alleged health data sharing and deceptive billing practices https://pharmadog.xyz/news/159704 pharmadog en 2026-07-29T19:14:46.000Z US releases $600M pledged to global vaccine alliance Gavi after year‑long delay https://pharmadog.xyz/news/159649 pharmadog en 2026-07-29T18:45:33.000Z FTC sues Hims & Hers for misleading consumers and privacy violations https://pharmadog.xyz/news/159629 pharmadog en 2026-07-29T18:43:38.000Z Caldera and Vidya secure $478M via reverse mergers to go public https://pharmadog.xyz/news/159605 pharmadog en 2026-07-29T18:11:22.000Z FDA and Capricor clash over Duchenne cell therapy efficacy at advisory committee https://pharmadog.xyz/news/160516 pharmadog en 2026-07-29T17:51:00.000Z FDA advisory panel rejects Capricor’s Duchenne cardiomyopathy cell therapy https://pharmadog.xyz/news/159309 pharmadog en 2026-07-29T17:27:21.000Z Teva says it has time to prepare for upcoming US tariffs on imported generic drugs https://pharmadog.xyz/news/159181 pharmadog en 2026-07-29T17:02:49.000Z NYU's Neil Vasan steps down as acting chair of FDA's oncology drug advisory committee https://pharmadog.xyz/news/159441 pharmadog en 2026-07-29T16:10:31.000Z FDA approves first freeze-dried plasma product for U.S. use https://pharmadog.xyz/news/158989 pharmadog en 2026-07-29T16:07:00.000Z Caldera Therapeutics merges with Synlogic, secures $278M to advance inflammation drug https://pharmadog.xyz/news/159136 pharmadog en 2026-07-29T16:00:00.000Z Vesa Pylvänäinen sells 117 Vaisala shares at €57 each https://pharmadog.xyz/news/159137 pharmadog en 2026-07-29T16:00:00.000Z Vaisala senior executive Vesa Pylvänäinen sells 117 shares at €57 each on Nasdaq Helsinki https://pharmadog.xyz/news/158990 pharmadog en 2026-07-29T15:40:00.000Z Vertex and AbCellera team up to develop next-generation T-cell engagers for autoimmune diseases https://pharmadog.xyz/news/158885 pharmadog en 2026-07-29T15:17:35.000Z Atea's hepatitis C combo therapy shows non-inferior results to Gilead's Epclusa https://pharmadog.xyz/news/158821 pharmadog en 2026-07-29T15:13:00.000Z Earnings roundup: Biogen’s ‘resiliency,’ AstraZeneca’s growth pitch and GSK’s oncology push https://pharmadog.xyz/news/158840 pharmadog en 2026-07-29T15:00:00.000Z Nokia senior manager Mikko Hautala buys 7,103 shares at €7.84 each https://pharmadog.xyz/news/158992 pharmadog en 2026-07-29T15:00:00.000Z FDA reviewers doubt Replimune’s melanoma therapy as shares tumble 40% https://pharmadog.xyz/news/158841 pharmadog en 2026-07-29T15:00:00.000Z Nokia senior manager Mikko Hautala buys 7,103 shares at €7.84 each https://pharmadog.xyz/news/158843 pharmadog en 2026-07-29T15:00:00.000Z Nokia reports senior executive Kristen Pressner purchases 66,324 shares at €7.84 each https://pharmadog.xyz/news/158842 pharmadog en 2026-07-29T15:00:00.000Z Nokia senior manager Kristen Pressner purchases 66,324 shares at €7.84 each https://pharmadog.xyz/news/158801 pharmadog en 2026-07-29T14:58:30.000Z Trump administration ends Medicare drug plan subsidies, raising cost concerns ahead of midterms https://pharmadog.xyz/news/158673 pharmadog en 2026-07-29T14:54:44.000Z Biogen shifts M&A strategy as Apellis acquisition pushes revenue above analyst expectations https://pharmadog.xyz/news/158649 pharmadog en 2026-07-29T14:46:38.000Z Two biotech firms announce reverse mergers to list experimental bispecific antibody and BTK inhibitor on Nasdaq https://pharmadog.xyz/news/159679 pharmadog en 2026-07-29T13:59:00.000Z Merck briefly lists, then removes, phase 2 trial of PD-1xVEGF bispecific with TROP2 ADC https://pharmadog.xyz/news/158505 pharmadog en 2026-07-29T13:37:24.000Z Kyverna partners with ElevateBio to supply its autologous CAR-T therapy for autoimmune launches https://pharmadog.xyz/news/158525 pharmadog en 2026-07-29T13:36:01.000Z Fugitive Discovered Working Under Alias in Biotech Industry Amid Legal Battles Involving AstraZeneca and Lilly https://pharmadog.xyz/news/158526 pharmadog en 2026-07-29T13:29:39.000Z Benchmarking Clinical LLMs Proves Complex After Recent Nature Medicine Study https://pharmadog.xyz/news/158506 pharmadog en 2026-07-29T13:26:04.000Z Oncology experience not always required for pharma jobs, recruiters say https://pharmadog.xyz/news/158507 pharmadog en 2026-07-29T13:21:03.000Z Biopharma job postings in New York rise 34% over past year, seven companies now hiring https://pharmadog.xyz/news/158357 pharmadog en 2026-07-29T12:56:26.000Z Incyte drops early-stage JAK2 inhibitor to prioritize next-generation pipeline https://pharmadog.xyz/news/158377 pharmadog en 2026-07-29T12:55:57.000Z Fauci invokes Fifth Amendment, declines to answer Covid-19 origins questions at Senate hearing https://pharmadog.xyz/news/158358 pharmadog en 2026-07-29T12:38:10.000Z Novo Nordisk faces shareholder fraud lawsuit over undisclosed dosing changes in CagriSema Phase 3 trial https://pharmadog.xyz/news/158057 pharmadog en 2026-07-29T12:00:44.000Z AI startup Doctronic acquires text-message pediatric care provider Summer Health https://pharmadog.xyz/news/159580 pharmadog en 2026-07-29T11:57:00.000Z Nanoparticle-loaded chemotherapy crosses blood-brain barrier in mice after glioblastoma surgery, study shows https://pharmadog.xyz/news/158101 pharmadog en 2026-07-29T11:50:20.000Z Morning Rounds flags overlooked pedestrian and cyclist deaths, upcoming Fauci Senate hearing, and research visa limits https://pharmadog.xyz/news/134233 pharmadog en 2026-07-29T11:49:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/123087 pharmadog en 2026-07-29T11:33:00.000Z BioSpace launches dashboard to track performance of U.S. biotech IPOs in 2026 https://pharmadog.xyz/news/158083 pharmadog en 2026-07-29T11:19:00.000Z FDA briefing hints tough road for Capricor and Replimune ahead of advisory committee meetings https://pharmadog.xyz/news/157929 pharmadog en 2026-07-29T11:00:37.000Z Former Recursion CEO Chris Gibson joins Dimension Capital as operating partner https://pharmadog.xyz/news/158860 pharmadog en 2026-07-29T10:52:00.000Z Biogen CEO says company will pause new acquisitions and focus on developing existing pipeline https://pharmadog.xyz/news/158624 pharmadog en 2026-07-29T10:30:00.000Z Novo Nordisk loses bid to dismiss lawsuit over CagriSema trial readout https://pharmadog.xyz/news/158625 pharmadog en 2026-07-29T10:12:00.000Z Processa Pharma acquires Vidya Therapeutics, gaining oral BTK inhibitor VT-7208 https://pharmadog.xyz/news/157633 pharmadog en 2026-07-29T10:00:26.000Z Leqembi posts $184M Q2 sales, best quarter since launch, Biogen lifts guidance https://pharmadog.xyz/news/157697 pharmadog en 2026-07-29T10:00:00.000Z STAT+: FDA expert panel recommends against approval of Capricor’s Duchenne drug https://pharmadog.xyz/news/158626 pharmadog en 2026-07-29T08:56:00.000Z Caldera Therapeutics completes reverse merger with Synlogic, secures $278 million financing https://pharmadog.xyz/news/157550 pharmadog en 2026-07-29T08:30:00.000Z Most-wanted fugitive Ronald Fischer operated under alias in biotech industry for two decades https://pharmadog.xyz/news/157549 pharmadog en 2026-07-29T08:30:00.000Z Study finds clinical chatbots lag behind general AI models in accuracy, sparking debate among doctors https://pharmadog.xyz/news/157552 pharmadog en 2026-07-29T08:30:00.000Z Prolonged hospital stays leave children isolated, urging change https://pharmadog.xyz/news/157551 pharmadog en 2026-07-29T08:30:00.000Z Former VA Secretary argues the Veterans Health Administration can boost US biotech competitiveness against China https://pharmadog.xyz/news/158171 pharmadog en 2026-07-29T08:09:00.000Z Vertex pays $28 million upfront to AbCellera for autoimmune T-cell engager collaboration https://pharmadog.xyz/news/156789 pharmadog en 2026-07-29T04:57:00.000Z Biotech earnings season kicks off as Agios reports Phase 2 setback for sickle-cell drug https://pharmadog.xyz/news/155785 pharmadog en 2026-07-28T23:34:07.000Z ADA faces member backlash and calls for CEO and CSO resignations after expert expulsions https://pharmadog.xyz/news/155358 pharmadog en 2026-07-28T21:15:04.000Z Webinar: Building the Intelligence Engine for Drug Discovery R&D Teams https://pharmadog.xyz/news/155054 pharmadog en 2026-07-28T19:29:57.000Z Six key issues we’re watching at Fauci’s hearing https://pharmadog.xyz/news/155010 pharmadog en 2026-07-28T19:08:10.000Z FDA reminds investors about the risks of advisory panels https://pharmadog.xyz/news/154794 pharmadog en 2026-07-28T18:33:11.000Z J&J proposes $5.5B talc settlement https://pharmadog.xyz/news/154795 pharmadog en 2026-07-28T18:08:40.000Z FDA offers updated guidance for generics of weight loss blockbusters https://pharmadog.xyz/news/154583 pharmadog en 2026-07-28T17:00:20.000Z Visa time limits on foreign Ph.D. students and postdocs will harm U.S. science, experts warn https://pharmadog.xyz/news/154584 pharmadog en 2026-07-28T16:37:26.000Z STAT+: Bracing for another Fauci hearing https://pharmadog.xyz/news/154426 pharmadog en 2026-07-28T16:02:00.000Z GSK prepares for patent cliff with $2.5B cost-cutting plan https://pharmadog.xyz/news/154245 pharmadog en 2026-07-28T15:17:47.000Z Oak Hill Bio merges with RA Capital SPAC; InnoCare's TYK2 drug hits in Phase 3 https://pharmadog.xyz/news/154246 pharmadog en 2026-07-28T15:05:10.000Z FDA staff say Replimune's melanoma trial failed to prove RP1 works https://pharmadog.xyz/news/154170 pharmadog en 2026-07-28T14:27:07.000Z GSK shares rise as $2.5B cost-cutting plan unveiled https://pharmadog.xyz/news/154146 pharmadog en 2026-07-28T14:24:45.000Z The future of gray-market peptides https://pharmadog.xyz/news/154082 pharmadog en 2026-07-28T14:11:41.000Z STAT+: GSK lays out plans to cut costs, pursue more late-stage drug trials https://pharmadog.xyz/news/154038 pharmadog en 2026-07-28T14:00:04.000Z Alnylam's stock is down 30% despite a booming biotech market. Here's why https://pharmadog.xyz/news/154083 pharmadog en 2026-07-28T13:39:53.000Z STAT+: FDA staff reiterate concerns about Replimune skin cancer treatment https://pharmadog.xyz/news/154084 pharmadog en 2026-07-28T13:25:49.000Z STAT+: Pharmalittle: We’re reading about FDA views on a Duchenne drug, GSK cost savings, and more https://pharmadog.xyz/news/154085 pharmadog en 2026-07-28T13:22:35.000Z STAT+: Three questions with Whoop’s new CMO https://pharmadog.xyz/news/154039 pharmadog en 2026-07-28T13:15:35.000Z Mirae raises $5.4M to turn patient texts into data for doctors https://pharmadog.xyz/news/154062 pharmadog en 2026-07-28T13:13:18.000Z FDA says Replimune’s melanoma data package is ‘not interpretable,’ setting up tough adcomm https://pharmadog.xyz/news/156404 pharmadog en 2026-07-28T13:07:00.000Z DSV A/S manager files share transaction report https://pharmadog.xyz/news/154985 pharmadog en 2026-07-28T13:02:00.000Z Eli Lilly tops new biopharma ranking on launch success, development speed https://pharmadog.xyz/news/153846 pharmadog en 2026-07-28T12:54:07.000Z Altimmune rises as GLP-1/glucagon drug curbs heavy drinking in mid-stage study https://pharmadog.xyz/news/153714 pharmadog en 2026-07-28T12:00:02.000Z Claris collects $118M to take eye drop into pivotal testing next year https://pharmadog.xyz/news/153778 pharmadog en 2026-07-28T12:00:00.000Z The FDA was all in on AI. Will that change? https://pharmadog.xyz/news/153779 pharmadog en 2026-07-28T12:00:00.000Z An eye drug biotech banks $118M and stocks its executive suite https://pharmadog.xyz/news/153758 pharmadog en 2026-07-28T11:57:15.000Z Anthony Fauci’s pandemic-era diary entries https://pharmadog.xyz/news/153715 pharmadog en 2026-07-28T11:35:41.000Z Updated: GSK reveals three-year blueprint to cut costs and propel R&D https://pharmadog.xyz/news/153621 pharmadog en 2026-07-28T11:12:55.000Z Apnimed eyes up to $160M IPO to prep for sleep apnea drug launch https://pharmadog.xyz/news/153622 pharmadog en 2026-07-28T11:06:13.000Z Oak Hill takes SPAC track to Nasdaq with Roche asset in tow https://pharmadog.xyz/news/153498 pharmadog en 2026-07-28T11:00:10.000Z Updated: Altimmune’s GLP-1-based shot cuts drinking in patients with alcoholism https://pharmadog.xyz/news/156405 pharmadog en 2026-07-28T11:00:00.000Z OKYO Pharma CSO Raj Patil boosts stake to 20,030 shares https://pharmadog.xyz/news/154220 pharmadog en 2026-07-28T10:33:00.000Z Incyte ditches phase 1-stage JAK inhibitor to pursue next-gen options https://pharmadog.xyz/news/154121 pharmadog en 2026-07-28T10:31:00.000Z Altimmune’s next-gen GLP-1 curbs heavy drinking in ‘unequivocal’ ph. 2 alcohol use disorder win https://pharmadog.xyz/news/153434 pharmadog en 2026-07-28T10:00:00.000Z STAT+: Preliminary trial results suggest a path to a safer Alzheimer’s treatment https://pharmadog.xyz/news/154122 pharmadog en 2026-07-28T09:52:00.000Z GSK unveils 3-year cost-saving plan to fund late-stage R&D, move research HQ to AZ's backyard https://pharmadog.xyz/news/154123 pharmadog en 2026-07-28T09:09:00.000Z Atea’s hepatitis C asset matches Gilead’s Epclusa in phase 3 trial https://pharmadog.xyz/news/154777 pharmadog en 2026-07-28T09:04:00.000Z Acrosian debuts as AI-focused biometrics CRO https://pharmadog.xyz/news/154013 pharmadog en 2026-07-28T08:55:00.000Z Guardant Health taps Patrick Dempsey for emotional colorectal cancer awareness video